- Investor's Business Daily•7 hours ago
Vertex was the big winner Friday following a slew of biotechs and drugmakers issuing first-quarter reports Thursday.
- Financial Times•12 hours ago
Biotech can easily get overshadowed by its larger and more profit-generating cousin, big pharma. However, the symbiosis between the two sectors has never been greater. Previously the small companies, usually ...
- Capital Cube•12 hours ago
Categories: Yahoo FinanceGet free summary analysis AstraZeneca Plc reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of AstraZeneca Plc – GlaxoSmithKline plc Sponsored ADR, Eli Lilly and Company, Johnson & Johnson, Abbott Laboratories and Biogen Inc. (GSK-US, LLY-US, JNJ-US, ABT-US and BIIB-US) that have also reported ... Read more (Read more...)
AZN: Summary for Astrazeneca PLC Common Stock - Yahoo Finance
AstraZeneca PLC (AZN)
NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
|Day's range||30.20 - 30.65|
|52-week range||25.55 - 35.04|
Trade prices are not sourced from all markets
|PE ratio (TTM)||21.92|
|Dividend & yield||1.90 (6.30%)|
|1y target est||N/A|